Erlend Petter Skagseth • 1955 • Paradis • 18 roles • 8 shareholdings

This website uses cookies to enhance the user experience.

Roles

Boards

Name	Role	Total operating income	Total equity	Shares
M MITOSIS AS	Contact Person	-	5,454,063	100 % directly
S SARSIA IV AS	Chairman	-	-31,888	15.77 % indirectly
A APIM THERAPEUTICS AS	Chairman	64,960	20,194,781	0.91 % indirectly
P PROPHYLIX PHARMA HOLDING AS	Board Member	-	19,595,007	0.62 % indirectly
R RECCURA THERAPEUTICS AS	Chairman	-	774,508	-
S SERCA PHARMACEUTICALS AS	Chairman	3,571,688	16,391,412	-
A AVEXXIN ONCOLOGY AS	Chairman	-	-78,133	-
S STIFTELSEN SINTEF	Alternate Member	364,551,000	3,024,072,000	-
S SEAFARM SOLUTIONS AS	Board Member	152,750	1,347,958	-
C CONNECT VEST	Board Member	5,257,202	1,938,608	-
B BOLIGSAMEIET ST. OLAVS VEI 25	Board Member	-	-	-
C CAEDO ONCOLOGY AS	Chairman	-	14,416,685	-
P PROPHYLIX AS	Board Member	-	-12,790,635	-
S SINTEF AS	Alternate Member	2,610,115,000	779,044,000	-
S SARSIA FOND III AS	Board Member	-	54,658,348	-
C CALLUNA PHARMA POOLCO AS	Chairman	-	-	-
M MED STORM INNOVATION AS	Board Member	4,970,331	-83,974	-

Last update: Aug 23, 2024

Shares owned by Erlend Petter Skagseth

Name	Share class	Total operating income	Total equity	Share
M MITOSIS AS	Ordinære aksjer	0	5,454,063	100 % directly
S SARSIA MANAGEMENT AS		24,404,210	8,720,742	15.77 % indirectly
S SARSIA IV AS		0	-31,888	15.77 % indirectly
S SARSIA SEED AS		0	53,493,715	3.25 % indirectly
A AQUILOZ AS		0	-674,876	1.03 % indirectly
A APIM THERAPEUTICS AS		64,960	20,194,781	0.91 % indirectly
S SEA-HAWK NAVIGATION AS		5,326,348	235,971	0.68 % indirectly
P PROPHYLIX PHARMA HOLDING AS		0	19,595,007	0.62 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025